Form 8-K - Current report:
SEC Accession No. 0001390478-19-000035
Filing Date
2019-07-15
Accepted
2019-07-15 16:56:13
Documents
1
Period of Report
2019-07-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sls-20190715x8xk.htm 8-K 60234
  Complete submission text file 0001390478-19-000035.txt   61633
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 19955589
SIC: 2834 Pharmaceutical Preparations